Mast cells and angiogenesis in haematological malignancies

Leukemia Research

Volumn 33, Issue 7, 2009, Pages 876-879

  Ribatti, Domenico ^a   Crivellato, Enrico ^b   Molica, Stefano ^c  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

^c PUGLIESE CIACCIO HOSPITAL   (Italy)

Author keywords

Angiogenesis; Haematological malignancies; Mast cells

Indexed keywords

ACUTE LYMPHOCYTIC LEUKEMIA; ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; B CELL LEUKEMIA; CELL FUNCTION; CHRONIC LYMPHATIC LEUKEMIA; HEMATOLOGIC MALIGNANCY; HUMAN; INFLAMMATORY CELL; LEUKEMIA; MAST CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR VASCULARIZATION;

ANIMALS; HUMANS; LEUKEMIA; MAST CELLS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 67349113437     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2009.02.028     Document Type: Review

References (47)

1. Crivellato E., and Ribatti D. Role of inflammatory cells in angiogenesis. In: Maragoudakis M.E., and Papadimitriou E. (Eds). Angiogenesis: basic sceince and clinical applications (2007), Transworld Research Network 229-246
2. Norrby K. Mast cells and angiogenesis. APMIS 110 (2002) 355-371
3. Qu Z., Liebler J.M., Powers M.R., Galey T., Ahmadi P., Huang X.N., et al. Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am J Pathol 147 (1995) 564-573
4. Qu Z., Huang X., Ahmadi P., Stenberg P., Liebler J.M., Le A.C., et al. Synthesis of basic fibroblast growth factor by murine mast cells. Regulation by transforming growth factor beta, tumor necrosis factor alpha, and stem cell factor. Int Arch Allergy Immunol 115 (1998) 47-54
5. Qu Z., Kayton R.J., Ahmadi P., Liebler J.M., Powers M.R., Planck S.R., et al. Ultrastructural immunolocalization of basic fibroblast growth factor in mast cell secretory granules. Morphological evidence for bFGF release through degranulation. J Histochem Cytochem 46 (1998) 1119-1128
6. Grutzkau A., Kruger-Krasagakes S., Baumesteir H., Schwarz C., Kogel H., Welker P., et al. Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF 206. Mol Biol Cell 9 (1998) 875-884
7. Abdel-Majid R.M., and Marshall J.S. Prostaglandin E2 induces degranulation-independent produxtion of vascular endothelial growth factor by human mast cells. J Immunol 172 (2004) 1227-1236
8. Ribatti D., Crivellato E., Candussio L., Nico B., Vacca A., Roncali L., et al. Mast cells and their secretory granules are angiogenic in the chick embryo chorioallantoic membrane. Clin Exp Allergy 31 (2001) 602-608
9. Norrby K., Jakobsson A., and Sörbo J. Mast cell-mediated angiogenesis: a novel experimental model using the rat mesentery. Virchows Arch B Cell Pathol Mol Pathol 52 (1986) 195-206
10. Norrby K., Jakobsson A., and Sörbo J. Mast-cell secretion and angiogenesis, a quantitative study in rats and mice. Virchows Arch B Cell Pathol Mol Pathol 57 (1989) 251-256
11. Metcalfe D.D., Baram D., and Mekori Y.A. Mast cells. Physiol Rev 77 (1997) 1033-1079
12. Blair R.J., Meng H., Marchese M.J., Ren S., Schwartz L.B., and Tonnesen M.G. Human mast cells stimulate vascular tube formation: tryptase is a novel potent angiogenic factor. J Clin Invest 99 (1997) 2691-2700
13. Muramatsu M., Katada J., Hayashi I., and Majima M. Chymase as a proangiogenic factor. A possibile involvement of chymase-angiotensin-dependent pathway in hamster sponge angiogenesis model. J Biol Chem 275 (2000) 5545-5552
14. Kanbe N., Tanaka A., Kanbe M., Itakura A., Kurosawa M., and Matsuda H. Human mast cells produce matrix metalloproteinase 9. Eur J Immunol 29 (1999) 2645-2649
15. Ribatti D., Roncali L., Nico B., and Bertossi M. Effects of exogenous heparin on the vasculogenesis of the chorioallantoic membrane. Acta Anatom 130 (1987) 257-263
16. Sörbo J., Jakobson A., and Norrby K. Mast cell histamine is angiogenic through receptors for histamine 1 and histamine 2. Int J Exp Pathol 75 (1994) 43-50
17. Cantarella G., Lempereur L., Presta M., Ribatti D., Lombardo G., Lazarovici P., et al. Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. FASEB J 16 (2002) 1307-1309
18. Ribatti D., Belloni A.S., Nico B., Salà G., Longo V., Mangieri D., et al. Tryptase- and leptin-positive mast cells correlate with vascular density in uterine leiomyomas. Am J Obstet Gynecol 196 (2007) 470.e1-470.e7
19. Ribatti D., Nico B., Belloni A.S., Vacca A., Roncali L., and Nussdorfer G.G. Angiogenic activity of leptin in the chick embryo chorioallantoic membrane is in part mediated by endogenous fibroblast growth factor-2. Int J Mol Med 8 (2001) 265-268
20. Meininger C.J., Brightman S.E., Kelly K.A., and Zetter B.R. Increased stem cell factor by hemangioma-derived endothelial cells. Lab Invest (1995) 166-173
21. Sillaber C., Baghestanian M., Hofbauser R., Virgolini I., Bankl H.C., Fureder W., et al. Molecular and functional characterization of the urokinase receptor on human mast cells. J Biol Chem 272 (1997) 7824-7832
22. Benitez-Bribiesca L., Wong A., Utrera D., and Castellanos E. The role of mast cell tryptase in neoangiogenesis of premalignant and malignant lesions of the uterine cervix. J Histochem Cytochem 49 (2001) 1061-1062
23. Ribatti D., Vacca A., Ria R., Marzullo A., Nico B., Filotico R., et al. Neovascularization, expression of fibroblast growth factor-2, and mast cell with tryptase activity increase simultaneously with pathological progression in human malignant melanoma. Eur J Cancer 39 (2003) 666-675
24. Ribatti D., Finato N., Crivellato E., Marzullo A., Mangieri D., Nico B., et al. Neovascularization and mast cells with tryptase activity increase simultaneously with pathologic progression in human endometrial cancer. Am J Obstet Gynecol 193 (2005) 1961-1965
25. Imada D., Shijubo N., Kojima H., and Abe S. Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma. Eur Resp J 15 (2000) 1087-1093
26. Ribatti D., Scavelli C., Roccaro A.M., Crivellato E., Nico B., and Vacca A. Hematopoietic cancer and angiogenesis. Stem Cells Dev 13 (2004) 484-495
27. Vacca A., Ribatti D., Roncali L., Ranieri G., Serio G., Silvestris F., et al. Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 87 (1994) 503-508
28. Vacca A., Ribatti D., Presta M., Minischetti M., Iurlaro M., Ria R., et al. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood 93 (1999) 3064-3073
29. Ribatti D., Vacca A., Nico B., Quondamatteo F., Ria R., Minischetti M., et al. Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma. Br J Cancer 79 (1999) 451-455
30. Ribatti D., Nico B., and Vacca A. Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma. Oncogene 25 (2006) 4257-4266
31. Vacca A., and Ribatti D. Bone marrow angiogenesis in multiple myeloma. Leukemia 20 (2006) 193-199
32. Ribatti D., Polimeno G., Vacca A., Marzullo A., Crivellato E., Nico B., et al. Correlation of bone marrow angiogenesis and mast cells with tryptase activity in myelodysplastic syndromes. Leukemia 16 (2002) 1680-1684
33. Ribatti D., Nico B., Vacca A., Marzullo A., Calvi N., Roncali L., et al. Do mast cells help to induce angiogenesis in B-cell non-Hodgkin's lymphomas?. Br J Cancer 77 (1998) 1900-1906
34. Ribatti D., Vacca A., Marzullo A., Nico B., Ria R., Roncali L., et al. Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. Int J Cancer 85 (2000) 171-175
35. Crivellato E., Nico B., Vacca A., Dammacco F., and Ribatti D. Mast cell heterogeneity in B-cell non-Hodgkin's lymphomas: an ultrastructural study. Leuk Lymphoma 43 (2002) 2201-2205
36. Crivellato E., Nico B., Vacca A., and Ribatti D. Ultrastructural analysis of mast cell recovery after secretion by piecemeal degranulation in B-cell non-Hodgkin's lymphoma. Leuk Lymphoma 44 (2003) 517-521
37. Nico B., Mangieri D., Crivellato E., Vacca A., and Ribatti D. Mast cells contribute to vasculogenic mimicry in multiple myeloma. Stem Cell Dev 17 (2008) 19-22
38. Perez-Atayde A.R., Sallan S.E., and Tedrow U. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphocytic leukemia. Am J Pathol 150 (1997) 815-821
39. Aguayo A., Kantarajian H., Manshouri T., Gidel C., Estey E., Thomas D., et al. Angiogenesis in acute and chronic leukemia and myelodysplastic syndromes. Blood 96 (2000) 2240-2245
40. Aguayo A.R., Estey E., Kantarajian T., Mansouri T., Gidel C., Keating M., et al. Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia. Blood 94 (1999) 3717-3721
41. Letilovic T., Vrhovac R., Verstovsek S., Jaksic B., and Ferrajoli A. Role of angiogenesis in chronic lymphocytic leukemia. Cancer 107 (2006) 925-934
42. Molica S., Vacca A., Ribatti D., Cuneo A., Cavazzini F., Levato D., et al. Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphatic leukemia. Blood 100 (2002) 3344-3351
43. Shanafelt T.D., and Kay N.E. The clinical and biologic importance of neovascularization and angiogenic signaling pathways in chronic lymphocytic leukemia. Semin Oncol 33 (2006) 174-185
44. Ribatti D., Molica S., Vacca A., Nico B., Crivellato E., Roccaro A.M., et al. Tryptase-positive mast cells correlate positively with bone marrow angiogenesis in B-cell chronic lymphocytic leukemia. Leukemia 17 (2003) 1428-1430
45. Molica S., Vacca A., Crivellato E., Cuneo A., and Ribatti D. Tryptase-positive mast cells predict clinical outcome of patients with B-cell chronic lymphocytic leukemia. Eur J Haematol 71 (2003) 137-139
46. Molica S., Vacca A., Tucci L., and Ribatti D. Reversal of bone marrow angiogenesis in chronic lymphocytic leukemia following fludarabine therapy. Haematologica 90 (2005) 698-700
47. Molica S., Montillo M., Ribatti D., Mirabelli R., Tedeschi A., Ricci F., et al. Intense reversal of bone marrow angiogenesis after sequential fludarabile-induction and alemtuzumab-consolidation therapy in advance chronic lymphocytic leukemia. Haematologica 92 (2007) 1367-1374